Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:CodeSystem ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "med-admin-route-cs"] ; #
fhir:language [ fhir:v "en"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem med-admin-route-cs</b></p><a name=\"med-admin-route-cs\"> </a><a name=\"hcmed-admin-route-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">IV-BOLUS<a name=\"med-admin-route-cs-IV-BOLUS\"> </a></td><td>Intravenous Bolus</td><td>Direct IV injection over <5 minutes.</td></tr><tr><td style=\"white-space:nowrap\">IV-PUSH<a name=\"med-admin-route-cs-IV-PUSH\"> </a></td><td>Intravenous Push</td><td>IV injection over 5–15 minutes.</td></tr><tr><td style=\"white-space:nowrap\">IV-INFUSION-SHORT<a name=\"med-admin-route-cs-IV-INFUSION-SHORT\"> </a></td><td>IV Short Infusion</td><td>IV infusion over 15 minutes to 3 hours.</td></tr><tr><td style=\"white-space:nowrap\">IV-INFUSION-LONG<a name=\"med-admin-route-cs-IV-INFUSION-LONG\"> </a></td><td>IV Long Infusion</td><td>IV infusion over >3 hours or continuous infusion.</td></tr><tr><td style=\"white-space:nowrap\">ORAL<a name=\"med-admin-route-cs-ORAL\"> </a></td><td>Oral</td><td>By mouth (tablets, capsules, solution).</td></tr><tr><td style=\"white-space:nowrap\">SUBCUTANEOUS<a name=\"med-admin-route-cs-SUBCUTANEOUS\"> </a></td><td>Subcutaneous</td><td>Injection into subcutaneous tissue.</td></tr><tr><td style=\"white-space:nowrap\">INTRAMUSCULAR<a name=\"med-admin-route-cs-INTRAMUSCULAR\"> </a></td><td>Intramuscular</td><td>Injection into muscle.</td></tr><tr><td style=\"white-space:nowrap\">INTRATHECAL<a name=\"med-admin-route-cs-INTRATHECAL\"> </a></td><td>Intrathecal</td><td>Into the cerebrospinal fluid (spinal canal).</td></tr><tr><td style=\"white-space:nowrap\">INTRAVESICAL<a name=\"med-admin-route-cs-INTRAVESICAL\"> </a></td><td>Intravesical</td><td>Into the bladder lumen.</td></tr><tr><td style=\"white-space:nowrap\">INTRAPERITONEAL<a name=\"med-admin-route-cs-INTRAPERITONEAL\"> </a></td><td>Intraperitoneal</td><td>Into the peritoneal cavity.</td></tr><tr><td style=\"white-space:nowrap\">INTRAPLEURAL<a name=\"med-admin-route-cs-INTRAPLEURAL\"> </a></td><td>Intrapleural</td><td>Into the pleural cavity.</td></tr><tr><td style=\"white-space:nowrap\">TOPICAL<a name=\"med-admin-route-cs-TOPICAL\"> </a></td><td>Topical</td><td>Applied to skin surface.</td></tr><tr><td style=\"white-space:nowrap\">TRANSDERMAL<a name=\"med-admin-route-cs-TRANSDERMAL\"> </a></td><td>Transdermal</td><td>Through intact skin via patch.</td></tr><tr><td style=\"white-space:nowrap\">INHALED<a name=\"med-admin-route-cs-INHALED\"> </a></td><td>Inhaled</td><td>Via inhalation.</td></tr><tr><td style=\"white-space:nowrap\">INTRALESIONAL<a name=\"med-admin-route-cs-INTRALESIONAL\"> </a></td><td>Intralesional</td><td>Injected directly into the lesion.</td></tr><tr><td style=\"white-space:nowrap\">INTRA-ARTERIAL<a name=\"med-admin-route-cs-INTRA-ARTERIAL\"> </a></td><td>Intra-arterial</td><td>Into a feeding artery (e.g., hepatic artery infusion).</td></tr></table></div>"^^rdf:XMLLiteral ]
] ; #
fhir:url [
fhir:v "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-admin-route-cs>
] ; #
fhir:version [ fhir:v "0.1.0"] ; #
fhir:name [ fhir:v "MedAdminRouteCS"] ; #
fhir:title [ fhir:v "Kenya Medication Administration Route Code System"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:experimental [ fhir:v false] ; #
fhir:date [ fhir:v "2026-06-04T14:49:30+00:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "Digital Health Agency (DHA), Kenya"] ; #
fhir:contact ( [
fhir:name [ fhir:v "Digital Health Agency (DHA), Kenya" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ] ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ] ] )
] [
fhir:name [ fhir:v "Digital Health Agency Kenya – FHIR Team" ] ;
( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ] ;
fhir:use [ fhir:v "work" ] ] [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ] ;
fhir:use [ fhir:v "work" ] ] )
] ) ; #
fhir:description [ fhir:v "Codes for the route by which oncology medications are administered."] ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [
fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
fhir:l <urn:iso:std:iso:3166> ] ;
fhir:code [ fhir:v "KE" ] ;
fhir:display [ fhir:v "Kenya" ] ] )
] ) ; #
fhir:caseSensitive [ fhir:v true] ; #
fhir:content [ fhir:v "complete"] ; #
fhir:count [ fhir:v "16"^^xsd:nonNegativeInteger] ; #
fhir:concept ( [
fhir:code [ fhir:v "IV-BOLUS" ] ;
fhir:display [ fhir:v "Intravenous Bolus" ] ;
fhir:definition [ fhir:v "Direct IV injection over <5 minutes." ]
] [
fhir:code [ fhir:v "IV-PUSH" ] ;
fhir:display [ fhir:v "Intravenous Push" ] ;
fhir:definition [ fhir:v "IV injection over 5–15 minutes." ]
] [
fhir:code [ fhir:v "IV-INFUSION-SHORT" ] ;
fhir:display [ fhir:v "IV Short Infusion" ] ;
fhir:definition [ fhir:v "IV infusion over 15 minutes to 3 hours." ]
] [
fhir:code [ fhir:v "IV-INFUSION-LONG" ] ;
fhir:display [ fhir:v "IV Long Infusion" ] ;
fhir:definition [ fhir:v "IV infusion over >3 hours or continuous infusion." ]
] [
fhir:code [ fhir:v "ORAL" ] ;
fhir:display [ fhir:v "Oral" ] ;
fhir:definition [ fhir:v "By mouth (tablets, capsules, solution)." ]
] [
fhir:code [ fhir:v "SUBCUTANEOUS" ] ;
fhir:display [ fhir:v "Subcutaneous" ] ;
fhir:definition [ fhir:v "Injection into subcutaneous tissue." ]
] [
fhir:code [ fhir:v "INTRAMUSCULAR" ] ;
fhir:display [ fhir:v "Intramuscular" ] ;
fhir:definition [ fhir:v "Injection into muscle." ]
] [
fhir:code [ fhir:v "INTRATHECAL" ] ;
fhir:display [ fhir:v "Intrathecal" ] ;
fhir:definition [ fhir:v "Into the cerebrospinal fluid (spinal canal)." ]
] [
fhir:code [ fhir:v "INTRAVESICAL" ] ;
fhir:display [ fhir:v "Intravesical" ] ;
fhir:definition [ fhir:v "Into the bladder lumen." ]
] [
fhir:code [ fhir:v "INTRAPERITONEAL" ] ;
fhir:display [ fhir:v "Intraperitoneal" ] ;
fhir:definition [ fhir:v "Into the peritoneal cavity." ]
] [
fhir:code [ fhir:v "INTRAPLEURAL" ] ;
fhir:display [ fhir:v "Intrapleural" ] ;
fhir:definition [ fhir:v "Into the pleural cavity." ]
] [
fhir:code [ fhir:v "TOPICAL" ] ;
fhir:display [ fhir:v "Topical" ] ;
fhir:definition [ fhir:v "Applied to skin surface." ]
] [
fhir:code [ fhir:v "TRANSDERMAL" ] ;
fhir:display [ fhir:v "Transdermal" ] ;
fhir:definition [ fhir:v "Through intact skin via patch." ]
] [
fhir:code [ fhir:v "INHALED" ] ;
fhir:display [ fhir:v "Inhaled" ] ;
fhir:definition [ fhir:v "Via inhalation." ]
] [
fhir:code [ fhir:v "INTRALESIONAL" ] ;
fhir:display [ fhir:v "Intralesional" ] ;
fhir:definition [ fhir:v "Injected directly into the lesion." ]
] [
fhir:code [ fhir:v "INTRA-ARTERIAL" ] ;
fhir:display [ fhir:v "Intra-arterial" ] ;
fhir:definition [ fhir:v "Into a feeding artery (e.g., hepatic artery infusion)." ]
] ) . #
IG © 2026+ Digital Health Agency (DHA), Kenya.
Package fhir.ke.nccp#0.1.0 based on FHIR 4.0.1.
Generated
2026-06-04
Links: Table of Contents |
QA Report